Biotech media outlet Labiotech.eu which covers the European Biotech industry, has today, 21 May 2019, listed Elasmogen CEO, Dr Caroline Barelle among top 20 women in leading biotech roles in Europe. The full article can be found...
Elasmogen CEO shortlisted for BBSRC Innovator of the Year 2019 award
Elasmogen is delighted to announce that shortlisted finalists for the 2019 BBSRC Innovator of the Year award include our CEO, Dr Caroline Barelle. The BBSRC Innovator of the Year award recognises the full breadth of impacts that BBSRC investments in research have...
Almac Discovery and Elasmogen to Share Anti-ROR-1 VNAR Data at American Association of Cancer Annual Meeting
Craigavon, N.I., UK, 20 Mar 2019 – Almac Discovery, a biopharmaceutical company focused on discovering and identifying innovative therapeutics for the treatment of cancer, and Elasmogen a biotech company developing next generation therapeutic biologics, today...
Elasmogen CEO Caroline Barelle Interviewed by Life Sciences Scotland for Leadership Insight
Life Sciences Scotland have interviewed Elasmogen's CEO Caroline Barelle as part of their Insight series. The article can be accessed here.
Elasmogen Licenses NDure™ Half-life Extension Technology to ImmunoForge
Novel soloMER based albumin binder will be used for two therapeutic fusion proteins™ Aberdeen, Scotland and Seoul, Korea; January 7th 2019: Elasmogen Ltd, developer of next generation soloMER biologics, announced today that ImmunoForge has entered a license agreement...
Elasmogen winner of BioFIT 2018 Start-up Slams
Lille, 5 December 2018 - Elasmogen wins another prestigious award during the 7th Edition of BioFIT. BioFIT is one of Europe's leading business conventions for technology transfer, academia-industry collaborations and early-stage innovations in the field of Life...
Elasmogen CEO Dr Caroline Barelle wins ‘Academic Entrepreneur of the Year’ award at Entrepreneurial Scotland’s Summit Awards 2018
Elasmogen’s CEO Dr Caroline Barelle won the Academic Entrepreneur of the Year award at Entrepreneurial Scotland's Summit Awards ceremony which took place on 22nd November 2018 in Glasgow. Commenting on her win, Caroline says "I am delighted to be recognised for...
Summit Awards – Celebrating Scottish Entrepreneurship
Dr. Caroline Barelle, CEO of Elasmogen, is shortlisted as one of 3 finalists in the Academic to Entrepreneur of the Year category. This category recognises an individual who has demonstrated an enterprising approach to developing and delivering enterprise and...
Elasmogen CEO Interviewed by Scottish Business News Network
Our CEO Caroline Barelle was interviewed by Scottish Business News Network. In her interview, Caroline discusses the journey of starting up Elasmogen and provides an insight into the ups and downs of those early days alongside a glimpse into where Elasmogen is now and...
Almac Discovery, Elasmogen and Innovate UK Collaborate to Develop VNAR Based Oncology Platform
£2M joint program receives grant to support research into next generation technology Craigavon, N.I., UK, 6 Aug 2018 – Almac Discovery, a biopharmaceutical company focused on discovering and identifying innovative therapeutics for the treatment of cancer, and...
Dr Caroline Barelle named “Rising Stars: Extraordinary Talent (2017)” at last night’s Scotland’s Life Sciences Dinner & Annual Awards.
17th May 2018: Aberdeen, Scotland: Elasmogen Ltd, developer of soloMERTM biologics, today announced that Dr Caroline Barelle was named as the winner in the “Rising Stars: Extraordinary Talent (2017)” category at last night’s Scotland’s Life Sciences Dinner &...
Elasmogen CEO has been selected as a finalist for the Rising Stars
Dr. Caroline Barelle (CEO) has been selected as a finalist for the Rising Stars: Extraordinary Talent Award. Some of Scotland’s most dynamic life sciences companies and business leaders have been shortlisted for the prestigious Scottish Life Sciences Awards 2018. Read...